Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

University of Miami Sylvester Comprehensive Cancer Center

D. Tripathy

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Underst…

Jaime Seltzer

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Anal Cancer: Risk Factors and Prevention

GRACE

P. Romesser

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of Co-Exi…

Insights from 2023 ASCO® Annual Meeting

A. Medford

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

Understanding Your Cancer Risk and Options for Cancer Prevention

Yale Cancer Center

V. Giri, T. Shroff

Managing the Benign Hematology Consult: Treatment Recommendations fo…

Indy Hematology Review

C. Kessler

NGS in Glioblastoma: Clinically Relevant Genomics

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

J. Morrissette

ctDNA and MRD: Who, What, and Then What?

Total Health

A. Parikh

Use and Interpretation of Molecular Genetics in Blood Cancer

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

J. Morrissette

Developing Novel Therapeutics for Brain Tumors in the Age of Genomic…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

E. Galanis